Loading...
Loading...
BMO Capital Markets maintains its Perform rating on Xilinx
XLNX and raises its price target to $44 from $41 on decent execution amid a difficult environment.
BMO Capital Markets says, "Xilinx beat consensus estimates for reported F3Q and for guidance for F4Q.
F3Q revenues were $511 mn, down 8% q-q, and EPS was $0.41, excluding a $0.06 tax benefit. Guidance is for F4Q revenues to be up 4% q-q, in line with our expectation, but above consensus' expectation for growth of 2%."
XLNX closed at $35.30 per share on Wednesday.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in